TABLE 4.
Species and study scope | Sample size | Diagnostic test | Prevalence in % (95% Confidence Interval) | Reference |
---|---|---|---|---|
Cattle | ||||
Subnational | 667 | RBT & c‐ELISA | 0.2 (0.0–1.1) d | Asakura et al. (2018a) |
673 | RBT & c‐ELISA | 7.0 (5.7–8.4) | ||
Subnational | 1,103 | RBT & c‐ELISA | 6.8 (5.4–8.5) | Assenga et al. (2015) |
Subnational | 410 | RBT & c‐ELISA | 5.6 (3.8–8.3) | Chitupila et al. (2015) |
Subnational | 1,376 | RBT & c‐ELISA | 1.0–11.4 a | Chota et al. (2016) |
Subnational | 192 | RBT & c‐ELISA | 4.2 a | Kayombo et al. (2017) |
Subnational | 658 | i‐ELISA | 5.4 a | Mathew, 2017) |
Subnational | 200 | RBT | 21.5 (16–27) | Mathew et al. (2015) |
i‐ELISA | 48.0 (41–55) | |||
Subnational | 296 | RBT & c‐ELISA | 7.8 a | Shirima and John (2016) |
Subnational | 929 | RBT & c‐ELISA | 2.8 (1.4–5.6) | Sagamiko et al. (2018) |
282 | RBT & c‐ELISA | 11.3 (9.4–13.5) | ||
Subnational | 2,723 | c‐ELISA | 4.9 a | Shirima et al. (2010) |
Subnational | 51 | RBT | 11.7 (9.1–14.9) | Swai and Schoonman (2012) |
Subnational | 655 | RBT | 5.3 (3.1–7.8) | Swai and Schoonman (2010) |
Subnational | 483 | RBT & c‐ELISA | 28.9 a | Shirima et al. (2014) |
Goats | ||||
Subnational | 248 | RBT & c‐ELISA | 1.6 (0.4–4.1) | Assenga et al. (2015) |
Subnational | 50 goats | RBT | 0 | Mathew et al. (2015) |
i‐ELISA | 2.0 (0.0–7.0) d | |||
Subnational | 75 | RBT & c‐ELISA | 0 | Shirima and John (2016) |
Subnational | c | RBT & c‐ELISA | 0 | Shirima et al. (2014) |
Sheep | ||||
Subnational | 35 | RBT | 0 | Mathew et al. (2015) |
i‐ELISA | 5.7 (0.0–17.0) d | |||
Subnational | 42 | RBT & c‐ELISA | 0 | Shirima and John (2016) |
Humans | ||||
Subnational | 340 | RBT, BAPA & Riv. T | 0.6 (0.1–2.1) | Assenga et al. (2015) |
Subnational | 455 | MAT & Blood culture | 3.5 a | Bouley et al. (2012) |
Subnational | 1,095 | MAT & Blood culture | 2.9 a | Carugati et al. (2018) |
Subnational | 562 | MAT | 6.9 a | Cash‐Goldwasser et al. (2017) |
Subnational | 370 | IgM‐ELISA , IgG‐ELISA & MAT | 7.0 a | Chipwaza et al. (2015) |
Subnational | 578 | b | 28.2 a | Chota et al. (2016) |
Subnational | 118 | MAT | 13.6 a | Crump et al. (2013) |
Subnational | 250 | SAT | 48.4 (42–54) | Mirambo et al. (2018) |
Subnational | 382 | Rapid Brucella serum agglutination | 14.1 (10.6–17.5) | Mngumi et al. (2016) |
Subnational | 148 | SAT | 58.1 (50–66) | Mujuni et al. (2018) |
Subnational | 13,642 | b | 5.8 a | Nonga and Mwakapeje (2017) |
Subnational | 82 | RBT & c‐ELISA | 0 | Shirima and John (2016) |
Subnational | 120 | c‐ELISA | 10.0 a | Shirima et al. (2014) |
Subnational | 460 | c‐ELISA | 8.3 a | Shirima et al. (2010) |
Abbreviations: BAPA, Buffered Acidified Plate Antigen Test; c‐ELISA, Competitive Enzyme‐Linked Immuno‐Sorbent Assay; i‐ELISA, Indirect Enzyme‐Linked Immuno‐Sorbent Assay; IgG‐ELISA, Immunoglobulin G Enzyme‐Linked Immuno‐Sorbent Assay; IgM‐ELISA, Immunoglobulin M Enzyme‐Linked Immuno‐Sorbent Assay; MAT, Microscopic Agglutination Test; RBT, Rose Bengal Test; Riv. T, Rivanol precipitation Test; SAT, Slide Agglutination Test.
Prevalence confidence interval not provided in the original article.
Diagnostic test not specified (Study based on health centre results’ records).
Sample size not specified.
The computed confidence interval value was <0.0.